Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562507/
https://www.ncbi.nlm.nih.gov/pubmed/34725217
http://dx.doi.org/10.1136/jitc-2021-003005corr1
_version_ 1784593272100880384
collection PubMed
description
format Online
Article
Text
id pubmed-8562507
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85625072021-11-15 Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors J Immunother Cancer Correction BMJ Publishing Group 2021-11-01 /pmc/articles/PMC8562507/ /pubmed/34725217 http://dx.doi.org/10.1136/jitc-2021-003005corr1 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_full Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_fullStr Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_full_unstemmed Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_short Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_sort correction: gb1275, a first-in-class cd11b modulator: rationale for immunotherapeutic combinations in solid tumors
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562507/
https://www.ncbi.nlm.nih.gov/pubmed/34725217
http://dx.doi.org/10.1136/jitc-2021-003005corr1

Ejemplares similares